PMA device
LifeVest Wearable Defibrillator
Zoll Manufacturing Corporation · Wearable Automated External Defibrillator (MVK, Class III) · First FDA decision Aug 17, 2009, newest Jun 30, 2023Ventricular arrhythmia and sudden cardiac arrest
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
10
PMA pathway
Device trials
12
Naming "LifeVest"
MAUDE reports
132,269
Brand "LifeVest", since 2015
PubMed studies
64
Mentioning "LifeVest"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing LifeVest Wearable Defibrillator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 10 decisions filed under this name.
- LifeVest Wearable DefibrillatorPMA supplement
P010030-S162 · Decided Jun 30, 2023 · 206 days after receipt · Normal 180 Day Track
Device type: Wearable automated external defibrillator (MVK) · Cardiology
- LifeVest Wearable Defibrillator (Model 4000)PMA supplement
P010030-S100 · Decided Jul 5, 2018 · 258 days after receipt · Normal 180 Day Track
Device type: Wearable automated external defibrillator (MVK) · Cardiology
- LifeVest Wearable DefibrillatorPMA supplement
P010030-S098 · Decided Feb 7, 2018 · 222 days after receipt · Normal 180 Day Track
Device type: Wearable automated external defibrillator (MVK) · Cardiology
3 more FDA decisions with a free account
Older decisions: P010030-S042, P010030-S023, P010030-S021, P010030-S011
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web BasedLocal determinationIn effectL34087CGS Administrators, LLCUpdated Aug 28, 2026
- Automatic External DefibrillatorsLocal determinationIn effectL33690CGS Administrators, LLCUpdated Feb 13, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "LifeVest", any status and sponsor, newest update first.
- Heart Failure Optimization StudyCompleted
Zoll Medical CorporationNot on our public-company list
NCT03016754 · 602 participants · Start Mar 1, 2017 · Primary completion Jun 1, 2022
Device: Wearable Cardioverter Defibrillator · For: Sudden Cardiac Death; Sudden Cardiac Arrest; Heart Failure and 1 more
Sites: Birmingham, Alabama; West Hills, California; Fernandina Beach, Florida · 67 sites in all
Zoll Medical CorporationNot on our public-company list
NCT03319160 · 1,164 participants · Start Feb 2, 2017 · Primary completion Sep 30, 2018
Device: Wearable Cardioverter Defibrillator · For: Sudden Cardiac Death; Left Ventricular Dysfunction; Cardiac Event and 1 more
Sites: Paris, France; Toulouse, France
- Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter DefibrillatorStatus unknown
Zoll Medical CorporationNot on our public-company list
NCT04504188 · 300 participants (planned) · Start Mar 8, 2021 · Primary completion Sep 2024
Device: Heart Rate Monitor Enhanced Treatment Optimization · For: Cardiomyopathies; Heart Failure
Sites: Cincinnati, Ohio; Kingwood, Texas; McKinney, Texas · 4 sites in all
9 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "LifeVest", and for the whole product code for context.
This brand
132,269 reports: 92,352 malfunction, 36,451 injury, 3,463 death
Whole product code MVK
133,849 reports: 93,827 malfunction, 36,492 injury, 3,526 death
Newest reports for this brand
- LifeVest WCD 5100 SystemInjury
ZOLL Manufacturing Corporation
3008642652-2026-10451 · Received Oct 30, 2026 · Event dated Oct 12, 2026
Device type: Wearable Automated External Defibrillator (MVK)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Skin Inflammation/ Irritation
- LifeVest WCD 4000 SystemMalfunction
ZOLL Manufacturing Corporation
3008642652-2026-10452 · Received Oct 30, 2026 · Event dated Oct 23, 2026
Device type: Wearable Automated External Defibrillator (MVK)
Device problem as coded: Circuit Failure; Contamination /Decontamination Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- LifeVest WCD 4000 SystemMalfunction
ZOLL Manufacturing Corporation
3008642652-2026-10453 · Received Oct 30, 2026 · Event dated Oct 23, 2026
Device type: Wearable Automated External Defibrillator (MVK)
Device problem as coded: Circuit Failure
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0353-2018 · Started Sep 12, 2017 · Posted by FDA Jan 14, 2018
Reason given: Incorrect service code for properly catching critical defects during self-check. Potential for defibrillation shock failure
Cause as FDA categorized it: Other · Device type: Wearable Automated External Defibrillator (MVK)
Z-0625-2011 · Started Sep 24, 2010 · Posted by FDA Dec 16, 2010
Reason given: The response button function may become intermittent. This can result in the device not progressing beyond the response button test during startup, which may prevent a conscious patient from delaying a treatment shock.
Cause as FDA categorized it: Other · Device type: Wearable Automated External Defibrillator (MVK)
Z-0883-2009 · Started Oct 21, 2008 · Posted by FDA Jan 28, 2009
Reason given: The charging circuit will not shut down properly.
Cause as FDA categorized it: Component design/selection · Device type: Wearable Automated External Defibrillator (MVK)
3 more recall records with a free account
Published research
The most relevant PubMed records for "LifeVest"[tiab]. The summary above synthesizes these.
- Wearable cardioverter defibrillators in schools: A guide for parents and educators.
Burch AE, Spar DS, Sears SF · Pacing Clin Electrophysiol · 2017
- Causes and clinical consequences of inappropriate shocks experienced by patients wearing a cardioverter-defibrillator.
Berger JM, Sengupta JD, Bank AJ, et al. · Heart Rhythm · 2023Research Support, Non-U.S. Gov't
- Processing compound words: Evidence from synaesthesia.
Mankin JL, Thompson C, Branigan HP, et al. · Cognition · 2016Research Support, Non-U.S. Gov't
- ICD early after myocardial infarction: it is really necessary to wait 40 days before implantation?
Bellicini MG, Cersosimo A, Cerini M, et al. · J Interv Card Electrophysiol · 2024Editorial
- An Electrical Storm Is Coming!: Ventricular Storm Case Study.
Sweeney M, Eldrich S · Adv Emerg Nurs J · 2022Case Reports
- False Alarms in Wearable Cardioverter Defibrillators-A Relevant Issue or an Insignificant Observation.
Dang PL, Lacour P, Parwani AS, et al. · J Clin Med · 2024
- Cost-utility analysis of the use of a wearable cardioverter defibrillator (LifeVest®) versus standard of care in the prevention of sudden cardiac death in patients after myocardial infarction.
Mitkowski P, Sterliski M, Czech M, et al. · Kardiol Pol · 2025Comparative Study, Research Support, Non-U.S. Gov't
- Update on Wearable Cardioverter Defibrillator: A Comprehensive Review of Literature.
Alsamman M, Prashad A, Abdelmaseih R, et al. · Cardiol Res · 2022Review
- Acute Lymphocytic Myocarditis in a Young Male Post-COVID-19.
Bohné M, Bohnen S, Willems S, et al. · Case Rep Cardiol · 2023Case Reports
- Should LifeVest Be Worn During Shower: A Case Report.
Lam VS, Huynh KH, Tran P · Cureus · 2025Case Reports
- Wearable cardioverter-defibrillator: friend or foe in suspected myocarditis?
Blaschke F, Lacour P, Dang PL, et al. · ESC Heart Fail · 2021Observational Study
- Assessing physical activity with the wearable cardioverter defibrillator in patients with newly diagnosed heart failure.
Iliodromitis K, Balogh Z, Triposkiadis F, et al. · Front Cardiovasc Med · 2023
Other devices of this type
Also filed under product code MVK.
- ASSURE Wearable Cardioverter Defibrillator (WCD) SystemKestra Medical Technologies, Inc. · PMA 2026
- Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) (Jewel)Element Science, Inc. · PMA 2025
- Wearable Cardioverter Defibrillator (Wcd) 2000 LifevestZoll Manufacturing Corporation · PMA 2018
- Lifevest Wcd 3000 SystemZoll Manufacturing Corporation · PMA 2002
- Hospital Wearable Defibrillator (Hwd 1000)Zoll Manufacturing Corporation · PMA 2017
- Lifevest Waerable DefibrillatorZoll Manufacturing Corporation · PMA 2012
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.